Aygün Ertuğrul

1995 yılında Hacettepe Üniversitesi Tıp Fakültesi’nden okul birincisi olarak mezun oldu. 1995-2000 yılları arasında Hacettepe Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalında uzmanlık eğitimini tamamladı. 2001-2002 yılları arasında Vanderbilt Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Psikofarmakoloji bölümünde Klinik Psikofarmakoloji üst uzmanlık eğitimi aldı. 2002 yılında Hacettepe Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalında öğretim görevlisi olarak göreve başladı, 2006 yılında doçent oldu. 2009 yılında Hacettepe Üniversitesi Nörolojik Bilimler ve Psikiyatri Enstitüsü’nde Temel Nörolojik Bilimler doktorasını tamamladı. 2011 yılında profesör oldu. 1995’te İhsan Doğramacı Bilim Ödülü’nü, 2002’de ABD’de NARSAD (National Alliance For Research on Schizophrenia and Depression) Genç Araştırmacı Ödülü’nü, 2003’te TÜBİTAK Beyin Araştırmaları Derneği Araştırma Projesi Teşvik Ödülü’nü, 2006’da European College of Neuropsychopharmacology (ECNP) Araştırma Ödülü’nü, 2012’ de Avrupa Psikiyatri Kongresi poster birincilik ödülü’nü aldı.

1. Autonomic Flexibility and Early Treatment Success: Heart Rate Variability Predicts Remission in First-Episode PsychosisRohde J., Weber S., de Bardeci M., Ertuğrul A., Amexi G., Schultz E., et al.Schizophrenia Bulletin, cilt.52, sa.5, 2026 (SCI-Expanded, SSCI, Scopus)
2. İnsan-bilgisayar etkileşimi kullanılarak insan niyetinin tespiti ve yeniden şekillendirilmesiŞENCAN C., Erkmen A. M., ERTUGRUL A.Afyon Kocatepe Üniversitesi Fen ve Mühendislik Bilimleri Dergisi, cilt.26, sa.3, ss.626-640, 2026 (TRDizin)
3. Remission of auditory verbal hallucinations following neuronavigated, personalized rTMS guided by EEG, MRI, and auditory evoked potentials: A case reportProvaznikova B., Monn A., ERTUĞRUL A., Weber S., Seifritz E., Jungwirth J., et al.Psychiatry Research Case Reports, cilt.5, sa.1, 2026 (Scopus)
4. Intention mining and intention reshaping: surfacing deep intentions by proactive visuals to morph them into new intentionsŞencan C., ERKMEN A. M., Ertuğrul A.Expert Systems with Applications, cilt.300, 2026 (SCI-Expanded, Scopus)
5. Exploring Cognitive Enhancements and Default Mode Network Connectivity in Relapsing-Remitting Multiple Sclerosis: Insights from a Prospective Study Investigating the MIND DietDEMİREL M., Dasgin H., Acar N. P., ÖZÇELİK EROĞLU E., ATABİLEN B., ERTUĞRUL A., et al.MULTIPLE SCLEROSIS JOURNAL, sa.3, ss.544, 2024 (SCI-Expanded, Scopus)
6. A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation.MUTLU E., ÖZÇELİK EROĞLU E., COŞKUN F. M., KOÇYİĞİT D., CANPOLAT İ. K. N., AVCI H., et al.Schizophrenia research, cilt.268, ss.138-144, 2024 (SCI-Expanded, SSCI, Scopus)
7. Eighteen years of the medical scientist training program at Hacettepe UniversityERDENER Ş. E., ERDENER Ş. E., ÖZÖN A., ÖZÖN A., ERTUĞRUL A., ERTUĞRUL A., et al.Acta Medica, cilt.55, sa.1, ss.29-36, 2024 (TRDizin)
8. The Role of Cannabis in the Development of PsychosisTurkoglu O., ERTUĞRUL A.TURK PSIKIYATRI DERGISI, cilt.35, sa.3, ss.234-244, 2024 (SSCI, Scopus)
9. Effects of Clozapine on Cortical InhibitionKaraçam Doǧan M., Yildiz F. G., TEMUÇİN Ç. M., ERTUĞRUL A.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, cilt.44, sa.1, ss.16-24, 2024 (SCI-Expanded, Scopus)
10. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactionsvan der Horst M. Z., Meijer Y., de Boer N., Guloksuz S., Hasan A., Siskind D., et al.Psychiatry Research, cilt.330, 2023 (SCI-Expanded, SSCI, Scopus)
11. Hodgkin Lymphoma in Patients Receiving Clozapine Treatment: 2 Case Reports and Literature Review.Doǧan M. K., Erdoǧan N. O., ERTUĞRUL A., Yaǧcioǧlu A. E., YAZICI M. S.Journal of clinical psychopharmacology, cilt.43, sa.2, ss.180-183, 2023 (SCI-Expanded, Scopus)
12. A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptomsAy S. B., Oguz K. K., Eroglu E. O., Has A. C., ERTUĞRUL A.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.38, 2023 (SCI-Expanded, Scopus)
13. Effect of clozapine on suicidality in patients with schizophrenia at a university hospital in TurkeyGürcan G., Şenol Ş. H., Yağcıoğlu A. E., ERTUĞRUL A.Schizophrenia Research, 2023 (SCI-Expanded, SSCI, Scopus)
14. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series El valproato, la obesidad y otras causas de metabolismo deficiente de la clozapina en el contexto de una titulación rápida de las dosis pueden explicar la miocarditis inducida por clozapina: un nuevo análisis de una serie de casos turcaERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Ağaoğlu E., Karakaşlı A. A., AK S., YAZICI M. S., et al.Revista de Psiquiatria y Salud Mental, cilt.15, sa.4, ss.281-286, 2022 (SCI-Expanded, SSCI, Scopus)
15. Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users A Systematic Review and A Case SeriesMutlu E., Dogan M. K., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, cilt.42, sa.3, ss.298-307, 2022 (SCI-Expanded, SSCI, Scopus)
16. Renal effects of long-term lithium therapy, revisitedYazici M. K., Eroglu E. O., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Agaoglu E., KARAHAN S., et al.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.37, sa.2, 2022 (SCI-Expanded, Scopus)
17. Effects of the COVID -19 pandemic on patients with schizophrenia spectrum disorders.ÖZÇELİK EROĞLU E., ERDOĞAN İ. M., Yıldız M., ANIL YAĞCIOĞLU A. E., TÜRKOĞLU Ö., YALÇINKAYA O. K., et al.Acta Medica, 2022 (TRDizin)
18. The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life of in schizophreniaMUTLU E., ABAOĞLU H., BARIŞKIN E., GÜREL Ş. C., ERTUĞRUL A., Yazici M. K., et al.SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, cilt.56, ss.1399-1410, 2021 (SCI-Expanded, SSCI, Scopus)
19. Common Side Effects and Metabolic Syndrome due to Clozapine: Relationship with the Clinical Variables and DisabilityGurcan G., Senol S. H., ANIL YAĞCIOĞLU A. E., KARAHAN S., ERTUĞRUL A.TURK PSIKIYATRI DERGISI, cilt.32, sa.2, ss.87-99, 2021 (SSCI, Scopus, TRDizin)
20. Augmentation of Clozapine Due to Inadequate Treatment Response in Schizophrenia: Comparison of Patients with Augmented and Non-augmented TreatmentsSenol S. H., Gurcan G., ERTUĞRUL A., KARAHAN S., ANIL YAĞCIOĞLU A. E.TURK PSIKIYATRI DERGISI, cilt.32, sa.1, ss.1-7, 2021 (SSCI, Scopus, TRDizin)
21. All in One Clozapine-Associated Acute Pancreatitis With Multiple Organ InvolvementYILDIZ M. İ., KARAÇAM DOĞAN M., Mutlu E., Abdullayeva L., ÖZMEN F., ERTUĞRUL A.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, cilt.41, sa.2, ss.214-216, 2021 (SCI-Expanded, Scopus)
22. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoringANIL YAĞCIOĞLU A. E., ERTUĞRUL A., KARAKAŞLI A. A., Ağaoğlu E., AK S., KARAHAN S., et al.Psychiatry Research, cilt.279, ss.90-97, 2019 (SCI-Expanded, SSCI, Scopus)
23. Examination of formal thought disorder and its clinical correlates with the Turkish Version of the Thought and Language Disorder Scale (TALD-TR) in schizophreniaMUTLU E., YAZICI M. K., BARIŞKIN E., ERTUĞRUL A., GÜREL Ş. C., Gürkan Ş., et al.Comprehensive Psychiatry, cilt.93, ss.7-13, 2019 (SCI-Expanded, SSCI, Scopus)
24. The Relationship of the Change in Symptoms and Cognitive Functions With the Change in Cortical Inhibition Parameters Measured by Transcranial Magnetic Stimulation: An Eight-Week Follow-Up StudyYILDIZ M. İ., Temucin Ç. M., ERTUĞRUL A.TURK PSIKIYATRI DERGISI, cilt.26, sa.3, ss.161-171, 2015 (SSCI, Scopus, TRDizin)
25. Effect of clozapine on white matter integrity in patients with schizophrenia: A diffusion tensor imaging studyOZCELIK-EROGLU E., ERTUĞRUL A., OGUZ K. K., Has A. C., KARAHAN S., YAZICI M. K.PSYCHIATRY RESEARCH-NEUROIMAGING, cilt.223, sa.3, ss.226-235, 2014 (SCI-Expanded, Scopus)
26. Language-dependent performance on the letter fluency task in patients with schizophreniaSUMIYOSHI C., ERTUĞRUL A., YAGCIOGLU A. E. A., Roy A., Jayathilake K., MILBY A., et al.SCHIZOPHRENIA RESEARCH, cilt.152, ss.421-429, 2014 (SCI-Expanded, SSCI, Scopus)
27. Language dependent performance on the letter fluency task in patients with schizophreniaSUMİYOSHİ C., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., ROY A., JAYATHİLAKE K., MİLBY A., et al.Schizophrenia Research, cilt.152, ss.421-429, 2014 (SCI-Expanded, SSCI, Scopus)
28. Effects of Acute and Chronic Electroconvulsive Shocks on Glycogen Synthase Kinase 3[beta] Level and Phosphorylation in MiceBAŞAR K., Eren-Kocak E., Ozdemir H., ERTUĞRUL A.JOURNAL OF ECT, cilt.29, sa.4, ss.261-266, 2013 (SCI-Expanded, SSCI, Scopus)
29. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compressionOLMEZ S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.PHARMAZIE, cilt.68, sa.2, ss.110-116, 2013 (SCI-Expanded, Scopus)
30. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in miceOZDEMIR H. Ö., ERTUĞRUL A., BAŞAR K., SAKA E.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.39, sa.1, ss.62-68, 2012 (SCI-Expanded, Scopus)
31. Psychiatric Disorders and EpigeneticsKOCAK E., ERTUĞRUL A.TURK PSIKIYATRI DERGISI, cilt.23, sa.2, ss.130-140, 2012 (SSCI, Scopus, TRDizin)
32. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampusERTUĞRUL A., OZDEMIR H., VURAL A., DALKARA T., Meltzer H. Y., SAKA E.BRAIN RESEARCH BULLETIN, cilt.84, sa.2, ss.144-150, 2011 (SCI-Expanded, Scopus)
33. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in TurkeyYAZICI M. S., YAGCIOGLU A. E., ERTUĞRUL A., ENI N., KARAHAN S., KARAAGAOGLU E., et al.EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, cilt.261, sa.1, ss.69-78, 2011 (SCI-Expanded, Scopus)
34. Orally disintegrating tablets ii: In vitro and in vivo evaluations Aǧızda daǧılan tabletler ii: In vitro ve in vivo deǧerlendirilmeleriÖlmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.Hacettepe University Journal of the Faculty of Pharmacy, cilt.31, sa.1, ss.59-70, 2011 (Scopus)
35. Effects of Self-Image on Identity Status Among Turkish AdolescentsCetin F. C., Ulay H. T.ADOLESCENT PSYCHIATRY, cilt.1, sa.1, ss.88-93, 2011 (SSCI, ESCI)
36. Antipsikotiklerin Kardiyak Yan EtkileriANIL YAĞCIOĞLU A. E., ERTUĞRUL A.Psikiyatride Güncel, cilt.1, ss.251-265, 2011 (Hakemli Dergi)
37. Orally disintegrating tablets i: Preparation technologies Aǧizda daǧilan tabletler i: Hazirlama teknolojileriÖlmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.Hacettepe University Journal of the Faculty of Pharmacy, cilt.30, sa.2, ss.205-230, 2010 (Scopus)
38. Anemia and Neutropenic Fever with High Dose Diazoxide Treatment in a Case with Hyperinsulinism Due to Munchausen by ProxyOzon A., DEMİRBİLEK H., ERTUĞRUL A., ÜNAL S., GÜMRÜK F., KANDEMİR N.JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.23, sa.7, ss.719-723, 2010 (SCI-Expanded, Scopus)
39. Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophreniaERGUN E. L., VOLKAN-SALANCI B., ERTUĞRUL A., DEMİR B., Erbas B.HELLENIC JOURNAL OF NUCLEAR MEDICINE, cilt.13, sa.1, ss.35-39, 2010 (SCI-Expanded, Scopus)
40. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment responseERTUĞRUL A., VOLKAN-SALANCI B., BAŞAR K., OGUZ K. K., DEMİR B., ERGUN E., et al.PSYCHIATRY RESEARCH-NEUROIMAGING, cilt.174, sa.2, ss.121-129, 2009 (SCI-Expanded, Scopus)
41. Neuroimaging Findings in Autism: A Brief ReviewULAY H. T., Ertugrul A.TURK PSIKIYATRI DERGISI, cilt.20, sa.2, ss.164-174, 2009 (SSCI, Scopus, TRDizin)
42. Semantic memory deficits based on category fluency performance in schizophrenia: Similar impairment patterns of semantic organization across Turkish and Japanese patientsSUMIYOSHI C., ERTUĞRUL A., Yagcioglu A. E., SUMIYOSHI T.PSYCHIATRY RESEARCH, cilt.167, ss.47-57, 2009 (SCI-Expanded, SSCI, Scopus)
43. Evoked Potentials and regional cerebral blood flow changes in conversion disorder: A case report and reviewGURSES N., TEMUÇİN Ç. M., ERGUN E., Ertugrul A., ÖZER S., DEMİR B.TURK PSIKIYATRI DERGISI, cilt.19, sa.1, ss.101-107, 2008 (SSCI, Scopus, TRDizin)
44. A randomized double blind comparison of clozapine and high doseolanzapine in treatment resistant patients with schizophreniaMELTZER H. Y., BOBO W., ROY A., JAYATHİLAKE K., CHEN Y., ERTUĞRUL A., et al.JOURNAL OF CLINICAL PSYCHIATRY, cilt.69, ss.274-285, 2008 (SCI-Expanded, SSCI, Scopus)
45. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophreniaMeltzer H. Y., Bobo W. V., Roy A., Jayathilake K., Chen Y., ERTUĞRUL A., et al.JOURNAL OF CLINICAL PSYCHIATRY, cilt.69, sa.2, ss.274-285, 2008 (SCI-Expanded, SSCI, Scopus)
46. Platelet and Plasma Serotonin Levels and Platelet Monoamine Oxidase Activity in Patients with Major Depression: Effects of Sertraline TreatmentBAKKALOGLU B., YABANOGLU S., OZYUKSEL B. R., UAAR G., ERTUĞRUL A., DEMİR B., et al.TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.33, sa.3, ss.97-103, 2008 (SCI-Expanded, TRDizin)
47. The effect of clozapine on neuroimaging findings in schizophreniaERTUĞRUL A., ULUG B.PSYCHIATRIA DANUBINA, cilt.19, sa.4, ss.367-369, 2007 (SCI-Expanded, Scopus)
48. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levelsErtugrul A., Ucar G., Basar K., Demir B., YABANOGLU S., ULUG B.PSYCHIATRY RESEARCH, cilt.149, ss.49-57, 2007 (SCI-Expanded, SSCI, Scopus)
49. Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: A case reportOzer S., Arsava M., Ertugrul A., Demir B.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.30, sa.4, ss.724-727, 2006 (SCI-Expanded, Scopus)
50. The neurobiology of hallucinationsErtugrul A., REZAKI M.TURK PSIKIYATRI DERGISI, cilt.16, sa.4, ss.268-275, 2005 (SSCI, Scopus, TRDizin)
51. Depresyon araştırmalarında kullanılan hayvan modelleriBAŞAR K., ERTUĞRUL A.Klinik Psikiyatri Dergisi, cilt.8, sa.3, ss.123-134, 2005 (TRDizin)
52. Clozapine-induced tardive dyskinesia: A case reportErtugrul A., DEMIR B.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.29, sa.4, ss.633-635, 2005 (SCI-Expanded, Scopus)
53. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patientsErtugrul A., YAGCIOGLU A. E., ENI N., YAZICI K.PSYCHIATRY AND CLINICAL NEUROSCIENCES, cilt.59, sa.2, ss.219-222, 2005 (SCI-Expanded, Scopus)
54. Creutzfeldt-Jakob disease: A case that initiated with psychiatric symptomsKURNE A., Ertugrul A., YAGCIOGLU A. E., DEMIRCI E., YAZICI K., KANSU T.TURK PSIKIYATRI DERGISI, cilt.16, sa.1, ss.55-59, 2005 (SSCI, Scopus, TRDizin)
55. Creutzfeldt Jakob disease A case that initiated with psychiatricsymptomsKURNE A., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., YAZICI M. K., DEMİRCİ E., KANSU T.TURK PSIKIYATRI DERGISI, cilt.16, ss.55-59, 2005 (SCI-Expanded, Scopus, TRDizin)
56. A double blind controlled study of adjunctive treatment with risperidonein schizophrenic patients partially responsive to clozapine Efficacyand safetyANIL YAĞCIOĞLU A. E., AKDEDE B. B., TURGUT T. İ., TÜMÜKLÜ M., YAZICI M. K., ERTUĞRUL A., et al.JOURNAL OF CLINICAL PSYCHIATRY, cilt.66, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)
57. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safetyYAGCIOGLU A. E., AKDEDE B., TURGUT T., TUMUKLU M., YAZICI M., ALPTEKIN K., et al.JOURNAL OF CLINICAL PSYCHIATRY, cilt.66, sa.1, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)
58. Psychopathology and personality features in orthopedic patients with boxer's fracturesMERCAN S., UZUN M., Ertugrul A., OZTURK I., DEMIR B., SULUN T.GENERAL HOSPITAL PSYCHIATRY, cilt.27, sa.1, ss.13-17, 2005 (SCI-Expanded, SSCI, Scopus)
59. Venous thromboembolism and escitalopramKURNE A., Ertugrul A., YAGCIOGLU A. E., YAZICI K.GENERAL HOSPITAL PSYCHIATRY, cilt.26, sa.6, ss.481-483, 2004 (SCI-Expanded, SSCI, Scopus)
60. A Comparison of Incidence of Diabetes Mellitus Between Atypical Antipsychotic Drugs A Survey for Clozapine Risperidone Olanzapine and QuetiapineSUMİYOSHİ T., ROY A., ANIL A. E., JAYAHTİLAKE K., ERTUĞRUL A., MELTZER H. Y.Journal of Clinical Psychopharmacology, cilt.24, ss.345-348, 2004 (SCI-Expanded, Scopus)

All 64 on AVESİS →

1. Imaging findings in patients with clozapine associated obsessive compusive disordersBıçakcı Ş., KARLI OĞUZ H. K., Has A., Bulut E., KARAHAN S., ERTUĞRUL A.27 th European Congress of Psychiatry, Varşova, Polonya, 6 - 09 Nisan 2019, cilt.56, ss.230, (Özet Bildiri)
2. EXAMINATION OF FORMAL THOUGHT DISORDER AND ITS CLINICAL CORRELATES WITH THE TURKISH VERSION OF THE THOUGHT AND LANGUAGE DISORDER SCALE (TALD-TR) IN SCHIZOPHRENIAMutlu E., YAZICI M. S., BARIŞKIN E., ERTUĞRUL A., GÜREL Ş. C., Gurkan S., et al.Congress of the Schizophrenia-International-Research-Society (SRIS), Florida, Amerika Birleşik Devletleri, 10 - 14 Nisan 2019, cilt.45, (Özet Bildiri)
3. Psikiyatri Servisine Yatırılarak Klozapin Başlanan Hastaların Sosyodemografik ve Klinik Özellikleri ve İlacın Kesilmesine Neden Olan Yan Etkiler.Ağaoğlu E., KARAKAŞLI A. A., AK S., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.54. Ulusal Psikiyatri Kongresi, Ankara, Türkiye, 2 - 06 Ekim 2018, cilt.29, ss.118, (Özet Bildiri)
4. A major challenge for clinicians: discussing rechallenge with clozapine through a case seriesHUN Ş., Gürcan G., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.EUROPEAN NEUROPSYCHOPHARMACOLOGY, Paris, Fransa, 2 - 05 Eylül 2017, cilt.27, ss.961, (Özet Bildiri)
5. Effect of clozapine on psychiatric comorbidities in patients with schizophreniaGürcan G., HUN Ş., ANIL YAĞCIOĞLU A. E., ERTUĞRUL A.EUROPEAN PSYCHIATRY, 1 - 30 Nisan 2017, cilt.41, ss.197, (Özet Bildiri)
6. Side effects of clozapine and their relationship with clinical variables in patients with schizophreniaGürcan G., HUN Ş., ANIL YAĞCIOĞLU A. E., ERTUĞRUL A.EUROPEAN PSYCHIATRY, 1 - 30 Nisan 2017, cilt.41, ss.197, (Özet Bildiri)
7. SWITCHING TO CLOZAPINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA: THE CLINICAL COURSE, REMISSION, AND AUGMENTATION OF TREATMENT AFTER THE SWITCHHUN Ş., Gürcan G., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.SCHIZOPHRENIA BULLETIN, San Diego, 24 - 28 Mart 2017, cilt.43, ss.202, (Özet Bildiri)
8. Yüksek Klozapin Kan Düzeyine Rağmen Toksisite Belirtisi Görülmeyen Bir OlguŞENOL G., GÜREL Ş. C., AYHAN Y., ERTUĞRUL A.50. Ulusal Psikiyatri Kongresi, Türkiye, 12 - 16 Kasım 2014, cilt.25
9. Yüksek klozapin kan düzeyi ve toksisite ilişkisi Bir olgu serisiŞEN Z. D., AYHAN Y., GÜREL Ş. C., BAŞAR K., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.TPD 18. Yıllık Toplantı ve Klinik Eğitim Sempozyumu, Türkiye, 23 - 26 Nisan 2014
10. İnhale eroin bağımlılığında yoksunluk antipsikotik tedavi ve deliryum gelişimi iki olgu sunumuGÜRCAN A., GÜREL Ş. C., BAŞAR K., AYHAN Y., ERTUĞRUL A., ULUĞ B. D.18. TPD Yıllık Toplantı ve Klinik Eğitim Sempozyumu, Antalya, Türkiye, 23 - 26 Nisan 2014, cilt.25, ss.30
11. Yüksek Klozapin Kan Düzeyi ve Toksisite İlişkisi Bir Olgu SerisiŞEN D. Z., AYHAN Y., GÜREL Ş. C., BAŞAR K., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.18.Yıllık Klinik Eğitim Sempozyumu, Türkiye, 23 Nisan 2014
12. Klozapin tedavisinin beşinci yılında ortaya çıkan tardif diskinezi tardif nokturnal akatizi ve tardif okülojiik distonikGÜREL Ş. C., ERTUĞRUL A., DEMİR B., ULUŞAHİN A.12.Türk Psikiyatri Dergi Yıllık Klinik Eğitim Sempozyumu, Türkiye, 23 - 27 Nisan 2008
13. The influence of clozapine treatment on plasma levels of reactive oxygen species and antioxidant enzymes in patients with schizophreniaYABANOĞLU ÇİFTÇİ S., ERTUĞRUL A., BAŞAR K., DEMİR B., UÇAR G., ULUĞ B. D.32nd FEBS Congress, Viyana, Avusturya, 7 - 12 Temmuz 2007, cilt.274, ss.283
14. Effects of Clozapine on Regional Cerebral Blood Flow in Patients with Schizophrenia Relationship with Neurocognitive Functions and Response to TreatmentERTUĞRUL A., ERGÜN E., BAŞAR K., VOLKAN SALANCI B., DEMİR B., ULUĞ B. D., et al.World Psychiatry Association International Congress, İstanbul, Türkiye, 12 - 16 Temmuz 2006, cilt.17, ss.305
15. Şizofreni hastalarında klozapinin beyin kan akımı üzerine etkisi bilişsel işlevler ve tedaviye yanıtla ilişkisiERTUĞRUL A., ERGÜN E., BAŞAR K., VOLKAN SALANCI B., DEMİR B., ULUĞ B. D., et al.1. Ulusal Psikofarmakoloji Kongresi, İstanbul, Türkiye, 14 - 17 Aralık 2005
16. Clozapine effect on rCBF in patients with treatment refractory schizophrenic patientsERTUĞRUL A., ERGÜN E., BAŞAR K., VOLKAN SALANCI B., DEMİR B., ULUĞ B. D., et al.Annual Congress of the European Associaton of Nuclear Medicine, İstanbul, Türkiye, 15 - 19 Ekim 2005, cilt.32, ss.194
17. Morphing Detected Human Intention Via Human-Computer InteractionsŞencan C., ERKMEN A. M., Ertuğrul A.
18. Clozapine and Long-Acting Injectable Antipsychotic Combination: A Retrospective Chart Review.MUTLU E., KARAÇAM M., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.
19. Effects of Clozapine on Cortical InhibitionKARAÇAM M., YILDIZ SARIKAYA F. G., TEMUÇİN Ç. M., ERTUĞRUL A.
20. Klozapinin uzun etkili enjekte edilebilir antipsikotiklerle kombinasyonuMUTLU E., KARAÇAM M., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.
21. Effect of clozapine on suicidality in patients with schizophrenia.GÜRCAN G., Hun Şenol Ş., ANIL YAĞCIOĞLU A. E., ERTUĞRUL A.
22. Effects of the COVID-19 pandemic on patients with schizophrenia spectrum disordersÖZÇELİK EROĞLU E., YILDIZ M. İ., ANIL YAĞCIOĞLU A. E., TÜRKOĞLU Ö., YALÇINKAYA O. K., ERTUĞRUL A., et al.
23. İNTRAVENÖZ EROİN KULLANIM BOZUKLUĞUNA EŞLİK EDEN TROpİKAMİD KÖTÜYE KULLANIMIBAĞCAZ A., GÜREL Ş. C., AYHAN Y., ERTUĞRUL A.
24. İnhale Eroin Bağımlılığında Yoksunluk Antipsikotik Tedavi ve Deliryum Gelişimi İki Olgu SunumuGÜRCAN A., GÜREL Ş. C., BAŞAR K., AYHAN Y., ERTUĞRUL A., ULUĞ B. D.
25. The effect of diazepam on performance of mice in forced swimming testERTUĞRUL A., BAŞAR K., REZAKİ M., DALKARA T.